THE ORAL PHARMACEUTICAL PREPARATION CONTAINING SARPOGRELATE
An orally administering pharmaceutical composition comprising sarpogrelate is provided to minimize the impurities generation rate during the storage, thereby capable of maintaining excellent chemical stability. An orally administering pharmaceutical composition comprises sarpogrelate or a salt there...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | An orally administering pharmaceutical composition comprising sarpogrelate is provided to minimize the impurities generation rate during the storage, thereby capable of maintaining excellent chemical stability. An orally administering pharmaceutical composition comprises sarpogrelate or a salt thereof, 0.5-10 wt.% of polyvinylacetate as a binding agent, and 0.5-10 wt.% of calcium stearate as a lubricant. The composition further comprises a pharmaceutically acceptable excipient, disintegrant, or stabilizer. |
---|